Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.

Authors

• Leslie Citrome
• Sheldon H Preskorn
• John Lauriello
• John H Krystal
• Rishi Kakar
• Jeffrey Finman
• Michael De Vivo
• Frank D Yocca
• Robert Risinger
• Lavanya Rajachandran

Publication/Presentation Date

10-3-2022

Volume

83

Issue

6

ISSN

1555-2101

Published In/Presented At

Citrome, L., Preskorn, S. H., Lauriello, J., Krystal, J. H., Kakar, R., Finman, J., De Vivo, M., Yocca, F. D., Risinger, R., & Rajachandran, L. (2022). Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial. The Journal of clinical psychiatry, 83(6), 22m14447. https://doi.org/10.4088/JCP.22m14447

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

36198061

Department(s)

Administration and Leadership

Document Type

Article